Single-Gene Risk™
What is our Single-Gene Risk test?
The Single-Gene Risk test identifies genetic variants associated with adult-onset health conditions, including cancer, cardiovascular diseases, and other health-related conditions. This test provides providers and patients with insights for proactive health management through early detection of variants shown to cause disease, personalized care, and risk stratification.
Why Choose MyOme's Single-Gene Risk
Comprehensive Insights
Clinically Actionable Reports
Re-analysis as Science Evolves
Disease Areas Covered
- Cardiovascular conditions
- Inherited forms of cardiomyopathies, arrhythmias, and lipids
- Cancers
- Inherited forms of breast, ovarian, colon, prostate, and skin cancers
- Other health conditions
- Inherited forms of diabetes, blood clotting disorders, metabolic conditions, metal metabolism disorders, and more
Who is this test for?
The Single-Gene Risk test helps healthy adults gain genetic insights, even without a strong personal or family history. It is not intended for diagnosing conditions based on family or personal history.
Test Code
PR21037
(Single-Gene Risk, Proactive Health Plus - 151 Genes)
PR22020
(Single-Gene Risk, Proactive Health - 84 Genes)
Turn Around Times
From samples received, most results are delivered in 5 to 6 weeks*.
If you've already had MyOme testing performed, follow-up testing or re-requisitions are typically completed in under 2 weeks, often within just a few days.
Acceptable Sample Types
- Blood
- Buccal
- Saliva
Discover which test is right for you
Proactive Health Plus
A comprehensive screening of 151 genes using 30x whole-genome sequencing, providing the ability for reanalysis and updated genetic information than panel based approaches or exomes.
Proactive Health
A more affordable option that screens 84 genes using blended genome-exome sequencing —offering a cost-effective option for preventative health decisions.
Interpreting Single-Gene Risk results
Important considerations
Patients with a personal or family history of a condition tested in the Single-Gene Risk test may need further screening or genetic testing.
The test is a screening tool and should not be used by those diagnosed with disease. A negative result doesn't eliminate the risk of developing a condition. MyOme offers genetic counseling to help with risk assessment and management.
Order a Single-Gene Risk test
Get more information on how to order a MyOme test and get the process started.
_Technical+One+Pager_Dec2024+thumbnail.jpg&w=1536&q=100)
